Billing for independent pathology labs, hospital-based pathology groups, dermatopathology, cytology and molecular labs.
A pathology group never meets the patient, so every dollar depends on a requisition someone else filled out. A missing ordering NPI, a hospital outpatient specimen billed under the wrong date of service, or four biopsies from one lesion billed as four specimens, and the claim denies or gets recouped months later. Luxen codes specimens, splits professional and technical components and works denials inside your LIS, with a BAA signed before we see any data and certified coders on every account.
On this page
Pathology billing services code, submit and collect for surgical, cytology, IHC and molecular pathology, applying specimen units, 26 and TC splits and Medicare date of service rules. A global 88305 pays $70.14 nationally in 2026. Ordering provider NPI was missing or invalid on 9% of lab claims (Luxen claim audit).
Most groups bill several service lines at once: surgical pathology, frozen sections, IHC and special stains, flow cytometry, FISH, molecular tests and clinical pathology consultations. Our certified medical coders code each line from the signed final report, and rebill when an addendum changes the diagnosis.
Pathology revenue leaks one unit, one component and one requisition at a time. Amounts are 2026 Medicare national payments (CAP 2026 impact table). Every row is a check in our denials and AR recovery work.
| Scenario | Codes | What goes wrong | $ at stake per claim | Luxen audit finding |
|---|---|---|---|---|
| Biopsies from one lesion sent in separate containers | 88305 with extra units | Units counted by container, not by specimen | $70.14 recouped per extra unit | Extra 88305 units for biopsies from one lesion appeared on 6% of pathology claims |
| Hospital outpatient specimen, independent lab bills Medicare | 88305-TC, 88342-TC | TC belongs to the hospital payment; the line denies and the hospital is never invoiced | $35.07 per 88305-TC line | Technical component claims for hospital outpatient specimens caused 11% of pathology denials |
| 12-core prostate needle biopsy | 88305 x 12 instead of G0416 | Medicare wants one unit of G0416 for all cores | $356.72 global claim denied | Prostate biopsy cases checked for G0416 before release |
| One antibody run on three blocks of one specimen | 88342, 88341 | Extra antibody units billed per block | $94.19 per 88341 unit denied | IHC units matched to specimen and antibody count |
| Requisition arrives without an ordering provider | Any, e.g. 88305 | Claim rejects and sits in a hold queue | $70.14 for one global 88305 | Ordering provider NPI was missing or invalid on 9% of lab claims |
Pathology is paid per specimen, per stain and per block, and most codes split into a professional component (modifier 26, the pathologist's interpretation) and a technical component (modifier TC, slide preparation). A global claim bills both. Payments below are 2026 Medicare national amounts at the $33.4009 conversion factor (CAP impact table).
| Code | Service | Global | 26 | TC |
|---|---|---|---|---|
| 88300 | Surgical pathology, gross exam only | $16.37 | $4.34 | $12.02 |
| 88302 | Surgical pathology, Level II | $32.73 | $6.68 | $26.05 |
| 88304 | Surgical pathology, Level III | $41.08 | $10.35 | $30.73 |
| 88305 | Surgical pathology, Level IV | $70.14 | $35.07 | $35.07 |
| 88307 | Surgical pathology, Level V | $277.90 | $76.49 | $201.41 |
| 88309 | Surgical pathology, Level VI | $413.50 | $134.61 | $278.90 |
| 88312 | Special stain, Group I (microorganisms) | $109.55 | $25.05 | $84.50 |
| 88313 | Special stain, Group II | $80.83 | $11.36 | $69.47 |
| 88331 | Frozen section, first block | $97.20 | $57.78 | $39.41 |
| 88332 | Frozen section, each additional block | $53.44 | $29.06 | $24.38 |
| 88342 | IHC, first antibody per specimen | $110.22 | $32.73 | $77.49 |
| 88341 | IHC, each additional antibody | $94.19 | $26.72 | $67.47 |
| 88173 | Fine needle aspirate evaluation and report | $166.67 | $65.47 | $101.20 |
| G0416 | Prostate needle biopsy, any method | $356.72 | $167.34 | $189.38 |
CMS cut work RVUs 2.5% for non-time-based services, a group that includes surgical pathology (CMS CY 2026 final rule fact sheet). The nonqualifying APM conversion factor rose 3.26%, so 88305 still moved from $69.54 in 2025 to $70.14.
Consults on clinical lab results bill with 80503 to 80506 (80503 pays $26.39), only when the attending physician requests one on an abnormal result and a written report goes in the record (42 CFR 415.130).
NCCI makes the specimen the unit of service for 88300 to 88309 and for frozen section codes. A specimen is tissue submitted for individual and separate attention, examination and diagnosis, usually in its own container. Two polyps at 15 cm and 25 cm can be two specimens; multiple biopsies of the same polyp are usually one (NCCI Policy Manual 2026, Chapter X). 88300, gross exam only, is never billed with 88302 to 88309 on the same specimen.
Since January 1, 2015, Medicare requires one unit of G0416 for all prostate needle biopsy specimens from a patient instead of 88305 per core (NCCI Policy Manual 2026, Chapter XII). G0416 pays $356.72 globally. Commercial payers set their own policy, so the code follows the payer on the claim.
Flow cytometry interpretation is one code for all markers on a specimen: 88187 for 2 to 8 markers, 88188 for 9 to 15 and 88189 for 16 or more. No code exists for a single marker. In cytopathology, modifier 59 or XS shows separate specimens from different anatomic sites.
Who may bill each component depends on where the specimen came from.
| Specimen source | Pathologist or lab bills Medicare | Technical component |
|---|---|---|
| Hospital inpatient or outpatient | 26 only | Paid inside the hospital facility payment |
| Physician office or freestanding ASC, sent to an independent lab | Global, or 26 and TC | Billed by the lab |
| In-office pathology lab in a GI, urology or dermatology group | Global by the group, or 26 by the pathologist | Anti-markup limits can apply |
For services after June 30, 2012, an independent lab may not bill Medicare for the technical component on a hospital inpatient or outpatient (42 CFR 415.130(d)(2)). CMS bundles it into the hospital's facility payment (CMS Transmittal R2714CP).
The date of service is the collection date (42 CFR 414.510). For a specimen taken during a hospital surgical procedure and stored 30 days or less, the lab uses the test date only when:
Molecular pathology tests, ADLTs, cancer-related protein-based MAAAs and 81490 take the test date when the test ran after the patient left the outpatient department, results do not guide treatment during that encounter and the test was medically necessary (42 CFR 414.510(b)(5)).
When a group bills the TC or PC of a test read by a physician who does not share its practice, Medicare pays the lowest of the reading physician's net charge, the group's actual charge or the fee schedule amount (42 CFR 414.50). Sharing means at least 75% of that physician's services go through the group, or reading as an owner, employee or contractor in the group's office.
The unit is a specimen submitted for separate attention, examination and diagnosis, and multiple biopsies of the same polyp are usually one specimen (NCCI Chapter X). Extra units are recouped at $70.14 each. Coding and modifier errors caused 21% of denials (Luxen claim audit).
For hospital inpatients and outpatients, an independent lab cannot bill Medicare for the TC of services after June 30, 2012 (CMS Transmittal R2714CP). Each 88305-TC line is $35.07 that will not pay. Technical component claims for hospital outpatient specimens caused 11% of pathology denials (Luxen claim audit).
Medicare uses the collection date unless the 14-day or molecular test conditions are met (42 CFR 414.510). A wrong date can push the corrected claim past the 1 calendar year filing limit (42 CFR 424.44). Timely filing caused 6% of denials, and only 4% of those were recovered (Luxen claim audit).
Medicare requires one unit of G0416 for all prostate needle biopsy specimens from a patient (NCCI Chapter XII). A 12-core case billed as 12 units of 88305 asks for $841.68 against a $356.72 allowed amount and denies. 19% of denied claims were never reworked or appealed (Luxen billing reviews).
Notice and consent does not apply to pathology (45 CFR 149.420), so the patient owes in-network cost sharing only and the dispute moves to open negotiation and IDR. Appeals filed by Luxen were overturned 68% of the time (Luxen client data).
We run the revenue cycle from eligibility to zero balance inside the practice management system you already use. How full-service billing works.
Certified coders review charges against your documentation and payer rules before the claim goes out, so the denial is prevented rather than appealed. Medical coding.
Aged and denied claims are worked to resolution, then the upstream cause is fixed so the same claims stop coming back. Denials and AR recovery.
Benefits are verified and authorizations secured before the appointment, which is the cheapest place in the cycle to stop a denial. Eligibility and prior authorization.
Statements, balance questions and payment plans are handled by the same team that worked the claim. Patient billing.
Payer enrollment and re-credentialing are tracked through to approval, so a lapsed credential never quietly stops payment. Credentialing.
A HIPAA-trained front-office assistant working inside your EHR on calls, scheduling, intake and referrals, alongside the billing team. Medical virtual assistant.
Pathology billing starts in the laboratory information system, not a clinic EHR. We bill from AP LIS platforms such as Epic Beaker, Oracle Health CoPathPlus, PowerPath, NovoPath and LigoLab, and from the billing modules tied to them. Referring clinic orders often arrive by interface from Epic, athenahealth, eClinicalWorks or NextGen, so we check demographics and insurance against the requisition before charges drop. Digital pathology and whole slide imaging systems stay as they are.
We get user access under your BAA and work inside your systems, with no migration. 38% had changed EHR or practice management system in the past five years (Luxen Practice Manager Survey 2026). Of those, 71% said collections dipped for at least six months after the switch.
2 weeks
from a signed BAA to our team working your claims
About 3 weeks
to the first recovered payments on aged AR
20+ years
combined billing and coding experience
Pathology findings from the Luxen claim audit (61,400 claims audited, Jan 2025 to Jun 2026) and Luxen billing reviews (410 practice billing reviews, Jan 2025 to Jun 2026):
Our accession log showed completed specimens that never appeared in the billing file. Luxen reconciled every case, identified 418 missed pathology services, and recovered $67,900 in one quarter.
Laboratory Administrator, independent pathology group
Molecular tests were being submitted before the order, diagnosis, and payer requirements were reviewed together. Luxen added a pre-bill checkpoint, reducing medical-necessity denials from 24% to 8% and recovering $116,300.
Revenue Cycle Director, anatomic and molecular pathology practice
Full engagements are written up in our dental practice case study and our ambulance billing case study.
Demographics, insurance, diagnosis and ordering provider all come from the requisition. Medicare does not need the ordering physician's signature on orders for physician pathology services, but medical necessity must be documented in the patient's record (CMS lab test order requirements). Electronic lab claims need the performing lab's CLIA number (Claims Processing Manual, Chapter 16). Ordering provider NPI was missing or invalid on 9% of lab claims (Luxen claim audit), so our eligibility and prior authorization team checks coverage and ordering data at accessioning.
MolDX covers Medicare in 28 states across the JM, JJ, JE, JF, J5, J8 and J15 jurisdictions, including North Carolina (Palmetto GBA MolDX). Lab claims there need a DEX Z-code: loop 2400 SV101-7 or box 19 on professional-format claims, per Noridian. Claims for the professional component alone do not (MolDX FAQ). Commercial genetic testing adds prior authorization; missing or invalid prior authorization caused 17% of denials (Luxen claim audit).
| KPI | What to watch | Luxen data |
|---|---|---|
| Days in AR | By payer, client account and specimen source | Pathology groups carried a median 52 days in AR (Luxen billing reviews) |
| First-pass denial rate | By denial reason and referring client | Across 38 client practices, first-pass denial rate fell from 14.2% to 6.1% within 90 days of onboarding (Luxen client data) |
| Unbilled accessions | Signed cases in the LIS with no charge | Accession log reconciled to the claim file weekly |
| AR ageing | Balances past 90 days by payer | Practices that reviewed AR ageing monthly carried 12 fewer days in AR (Luxen billing reviews) |
The pathologist bills apart from the surgeon who took the specimen. Under the physician fee schedule, Medicare patients owe 20% after the Part B deductible (Medicare.gov), while clinical lab tests on the lab fee schedule carry no deductible or coinsurance (Claims Processing Manual, Chapter 16, section 30.2). ACA plans must cover pathology on a polyp removed during a screening colonoscopy without cost sharing (DOL ACA FAQs Part XXIX). Practices lost 3.1% of collections to patient balances written off before a second statement (Luxen client data), so our patient billing team sends plain-language statements.
Pathology is an ancillary service, so an out-of-network pathologist at an in-network facility cannot use notice and consent to balance bill (45 CFR 149.420). The plan owes an initial payment or denial within 30 calendar days of the bill (45 CFR 149.120). The group then has 30 business days of open negotiation and 4 business days after that to start federal IDR (45 CFR 149.510). Some states add their own process for state-regulated plans: Texas offers mandatory arbitration for facility-based providers and out-of-network laboratory services (Tex. Ins. Code 1467.084).
The CY 2027 proposed rule sets the nonqualifying APM conversion factor at $32.84, down 1.68% from $33.40 (CMS fact sheet), and lists 88305 and 88307 in a request to revalue physician work time from empiric data (Federal Register). ASCP reports a cut of about 4% to global 88305, with the TC down about 5% and the PC about 2% (ASCP). Comments were due September 14, 2026.
3% to 6% of collections
Luxen's pricing generally falls between 3% and 6% of collections, depending on claim volume, specialty, payer mix, and how much of the revenue cycle your practice hands over.
Higher-volume practices usually land toward the lower end. Smaller or more complex practices land higher because there is more work per account. There is no setup fee and no exit fee, and the agreement runs month to month with 30 days notice.
A lower fee attached to weak billing is still expensive. The number that matters is what your collections do after you hire someone.
Luxen charges 3% to 6% of collections, set by specimen volume, the mix of global, professional and technical claims, and molecular authorization work. No setup or exit fee.
| Service line | Monthly collections | Luxen at 3% | Luxen at 6% |
|---|---|---|---|
| Surgical pathology, global and TC | $80,000 | $2,400 | $4,800 |
| IHC and special stains | $30,000 | $900 | $1,800 |
| Hospital professional component (26) | $25,000 | $750 | $1,500 |
| Cytology, flow cytometry and molecular | $15,000 | $450 | $900 |
| Total | $150,000 | $4,500 | $9,000 |
| Cost | In-house | Luxen |
|---|---|---|
| Monthly | $11,850 (7.9% of collections) | $4,500 to $9,000 |
| Annual | $142,200 | $54,000 to $108,000 |
| When a biller leaves | Open biller roles took a median 67 days to fill | Coverage continues |
| Terms | Salaries, benefits, LIS billing module seats and coding education | Month to month, 30 days notice |
Fully loaded in-house billing cost 7.9% of collections for practices under $2M, across 96 practices that shared payroll data (Luxen billing reviews). This example group collects $1.8M a year. For practices collecting $1.5M to $3M a year, every 10 days removed from AR released a median $41,000 in cash (Luxen billing reviews).
| Partner type | Specimen and unit checks | Hospital, office and molecular rules | Reporting | Terms |
|---|---|---|---|---|
| In-house biller | Depends on one person | Often learned from denials | Built by your team | Payroll and turnover |
| Generalist billing company | Standard claim scrubber | Often professional claims only | Standard aging | Often annual |
| Specialty pathology billing company | Usually built in | Varies by vendor | Varies | Varies |
| LIS or EHR vendor RCM | Software edits | Limited outside the platform | Inside the platform | Tied to the software contract |
| Luxen | Pre-bill specimen, unit and component check | Included, with DEX Z-codes and NSA deadlines | Monthly denials and AR by payer, client and specimen source | Month to month, 30 days notice |
Compare medical billing companies, or see what full-service medical billing includes.
A 30-minute look at your AR ageing, denial reasons and payer mix. You leave knowing what is recoverable, what we would work first and what it would cost.
We sign a business associate agreement before anyone touches your system. Your named team then works inside the practice management system and clearinghouse you already use. Nothing is migrated, and claims are being worked within two weeks of the signed BAA.
Aged and denied claims come first because that is revenue you have already earned. Most practices see the first recovered payments inside three weeks.
Once the backlog is moving, we take over the agreed part of the daily cycle: eligibility, coding review, submission, posting, denials and patient balances.
You know who owns your claims. The team works inside the practice management system and EHR you already run, with no migration.
Claims are coded by certified coders against your documentation and payer rules. Automation handles the repetitive checks so people spend their time on the claims that need judgment.
We sign a business associate agreement before accessing protected health information, and access is limited to the named people on your account.
We look at your AR ageing, volume, payer mix and denial profile first, then tell you what we believe is recoverable and what it would cost.
A billing company is a poor fit if you are not willing to share visibility into your billing, if the vendor uses a rotating pool of people who never learn your practice, or if it cannot explain why your claims are being denied. Be wary of anyone promising large collection increases before they have seen your AR ageing. The right partner makes your revenue cycle more visible, not less.
The pathologist who examined the tissue bills separately from the surgeon or clinic that collected it. For Medicare patients, physician pathology services carry the Part B deductible and 20% coinsurance, while clinical lab tests on the lab fee schedule carry neither. ACA plans must cover pathology on a polyp removed during a screening colonoscopy without cost sharing.
Luxen charges 3% to 6% of collections, with no setup or exit fee. A group collecting $150,000 a month would pay $4,500 to $9,000. For scale, Medicare pays $70.14 nationally for a global 88305 in 2026, so a fee on collections stays tied to what payers actually pay.
About 2 weeks from signed BAA to working claims. Median time from signed BAA to first claims worked was 9 business days, and first recovered payments arrived a median of 17 days after work began (Luxen client data). We work the oldest claims first, because Medicare closes filing 1 calendar year after the date of service.
Yes. We work inside AP LIS platforms such as Epic Beaker, CoPathPlus, PowerPath, NovoPath and LigoLab through user access granted under your BAA, with no data migration. We also confirm the performing lab's CLIA number is on every electronic lab claim, which Medicare requires.
Medicare requires one unit of G0416 for all prostate needle biopsy specimens from a patient, however many cores were taken, a rule in place since January 1, 2015. G0416 pays $356.72 globally in 2026. Billing 88305 per core denies.
Thirty minutes, no deck and no fee. We look at what is sitting past 90 days and where your denials cluster, and you leave knowing what is recoverable, what we would work first, and what it would cost.
Book a Billing Review%20(1).avif)
